INTRODUCTION
Stroke is a time-critical medical emergency requiring specialized treatment. The medical and economic burden of stroke can be mitigated by therapies focusing on rapid reperfusion of the occluded blood vessel and protection of viable nervous tissue in the penumbra (neuroprotection). [1] healthcare services to individuals who are at a distance from a specialized healthcare provider [9] and has shown to be a valid, accurate and reliable tool for improving in-hospital stroke care. [8, 10, 11] Research on prehospital telemedicine for acute stroke care is a promising concept [12] and is recommended by the American Stroke Association, [13] but exploration of realtime in-ambulance telestroke has been limited to studies in healthy volunteers [14] [15] [16] and two feasibility studies in patients during emergency missions. [17, 18] A pilot study evaluating the safety and the technical feasibility of inambulance telestroke is currently ongoing (Pre-hospital Stroke Study at the Universitair ziekenhuis Brussel I, PreSSUB I).
PreSSUB II will evaluate the efficacy, safety, feasibility, reliability and cost-effectiveness of in-ambulance telemedicine for patients with suspicion of acute stroke. We hypothesize that in-ambulance telestroke will reduce the delay to in-hospital treatment by streamlining the diagnostic process and that pre-hospital stroke care will be improved by expert stroke support via telemedicine during the ambulance transportation.
MATERIALS AND METHODS

Design
The PreSSUB II is an interventional, prospective, randomized, open-blinded, end-point, single-center trial comparing standard emergency care by the Paramedic Intervention Team (PIT) of the Universitair Ziekenhuis Brussel (UZB) (control) with this standard emergency care complemented with in-ambulance teleconsultation service by stroke experts (PreSSUB).
Randomization
Randomization is obtained on a weekly basis by block randomization using two alternative blocks of 4 weeks, i.e. "PreSSUB -control -PreSSUB -control" or "control -PreSSUB -control -PreSSUB." All patients will receive in-hospital care and follow-up according to current standing operating procedures of the UZB [ Figure 1 ]. The outcome parameters will be assessed by raters who are blinded for the treatment allocation.
Patient population
The PIT of the UZB serves the area of the northwest of Brussels, consisting of about half a million inhabitants. The catchment area is identical during the control weeks and the PreSSUB weeks. The PIT is available 24 h a day, 7 days a week as part of routine clinical practice. Additionally, round-the-clock availability of the prehospital telemedicine service will be provided during the PreSSUB weeks.
We will include all patients who are transported to the UZB by the PIT of the UZB for symptoms suggestive of a stroke with onset less than 12 h or unknown time of onset, unless patients are younger than 18 years. A clinical suspicion of stroke will be based on any of the symptoms mentioned in the Belgian Manual for Medical Regulation of Prehospital Care, [19] including hemiparesis, facial asymmetry, speech disturbance, sudden severe headache or confusion. Patients in whom in-ambulance telemedicine consultation would delay any diagnostic or therapeutic intervention are excluded.
Given the time-critical nature of acute stroke care, and in line with the procedure applied in the FACT Figure 1 : The study design of the prehospital stroke study at the Universitair ziekenhuis Brussel II Source: Based on the information provided during the emergency call, the emergency call-taker will dispatch the Paramedic Intervention Team (PIT) of the Universitair Ziekenhuis Brussel to the patient. Eligible patients are allocated on a weekly basis to either standard care (control) or standard care supplemented with in-ambulance telemedicine (PreSSUB). All patients receive standard in-hospital care and long-term follow-up. The call-to-brain imaging time is registered as the primary efficacy endpoint study, [18] informed consent will be requested based on the "opt-out sampling" principle. This implies that consent will be requested from the patients or their legal representatives after the ambulance transportation, when the patient has been stabilized in the hospital. The study protocol and the consent process were approved by the ethics committee of the UZB (EUDRACT 2014-003463-38). The study was registered at clinicaltrials.gov (NCT02270541).
Control
During control weeks, patients receive standard emergency care by the PIT of the UZB according to current clinical practice based on the standing operating procedures and the Belgian legislation. [20] Upon emergency call by a patient or bystander, the emergency call-taker dispatches the PIT to the patient's location in accordance with the Belgian Manual for Medical Regulation for Prehospital Care. [19] The PIT nurse may at all times request telephone support by a dedicated in-hospital emergency physician or on-site support by a medical emergency team consisting of an emergency physician and an emergency nurse.
Intervention
The in-ambulance teleconsultation service is provided 24/7 during the PreSSUB weeks. After notification by the PIT-nurse, the teleconsultant accesses the secured web-based telemedicine platform using a dedicated laptop and WiFi or 3G/4G connection. Teleconsultations are performed by the National Institutes of Health Stroke Scale-certified stroke experts with experience in telestroke and the Unassisted Telestroke Scale (UTSS, Table 1 ). [15, 18, 21] Patients are examined in the ambulance via bidirectional audio -video communication using the PreSSUB device [ Figure 2 ] while secured on a stretcher in the supine position, in line with safety regulations. The head of the stretcher is positioned according to patient's condition (preferably at 30 degrees). The ambulance is normally lit (standard lightning) and the sirens are activated as required. All patients will receive care by the PIT-nurses according to the current clinical practice based on standing operating procedures. [20] After the patient is brought aboard the ambulance, the vital functions and glycemia are registered using the PIT's standard equipment and are orally communicated to the teleconsultant or observed on the Assess the clarity of articulation throughout the entire examination 0 Normal articulation 1 Dysarthria Spatial attention and left/ right orientation Assess spatial attention and left/right orientation throughout the entire examination 0 Normal 1 Hemi-inattention or left/right confusion Assessment of the 16 items is facilitated and standardized by a software tool, presenting the instructions to the rater in the language preferred by the patient (Dutch, French or English). The text between quotation marks should be read literally to the patient monitor screen by the teleconsultant. Patient identification is obtained using the patient's e-ID card, if available. After insertion of the e-ID card in the telemedicine device, the patient's name and date of birth are automatically sent to the web-based telemedicine platform [ Figure 3 ]. The teleconsultant can support the PIT-nurse for obtaining and maintaining homeostasis during ambulance transportation. If necessary, the teleconsultant can assist the PIT-nurse for optimal application of the PIT's standard operating procedures regarding airway protection, blood oxygen saturation, arterial blood pressure, heart rate, cardiac arrhythmia, decreased level of consciousness, dysglycemia and other supportive measures (e.g., anti-emetics, analgetics). Whenever possible and without interfering with the PIT's routine practice, the teleconsultant assesses the patient's neurological status using the Glasgow Coma Scale (GCS) and the UTSS. The teleconsultant attempts to take a medical history from the patient focusing on the time of symptom onset, past medical history and medication use. The teleconsultant may formulate a preliminary diagnosis and attempts can be made to identify potential candidates for recanalization therapy. Additionally, information can be gathered regarding body weight, prehospital interventions, contact information of the family or prestroke functional state. The teleconsultant may activate the "Code Stroke" procedure (prioritized in-hospital care for patients with suspicion of acute stroke) if a potential candidate for recanalization therapy is identified. For this, he activates an automated message from the telemedicine platform to notify the in-hospital stroke team (consisting of an emergency physician, neurologist and neuroradiologist). All acquired data are communicated to the in-hospital team via personal, password-protected encrypted access to the teleconsultation report on the telemedicine platform. The report can be accessed by emergency physicians, radiologists and neurologists involved in the patient's care using any computer, tablet or smartphone with access to the Internet. Upon arrival at the hospital, patient care continues according to current clinical practice. To evaluate and scrutinize the teleconsultation, screen recordings from the teleconsultant's computer are made. These will be used for intra-and interrater evaluation of the various clinical scales and the care process. The bandwidth and technical issues of the mobile connection during the teleconsultation will be measured at the teleconsultant's side using bandwidth monitoring software.
Outcomes
Efficacy analysis
The primary endpoint is the call-to-brain imaging time, referring to the interval between the emergency call to the emergency dispatch center and the in-hospital brain Figure 3 : The PreSSUB telemedicine platform Source: Screen print of the PreSSUB telemedicine platform showing the clinical support system for stroke diagnosis. The left side of the screen shows video input from the ambulance (i.e., the patient spreading the fingers of her right hand). The right side shows the submenu of the support system that is activated (i.e., item 10 of the Unassisted TeleStroke Scale in the language preferred by the patient). Navigation between the various submenus is facilitated via touch screen activation of the buttons at the bottom imaging, either by computed tomography or magnetic resonance imaging. An average time gain of 20 min in the diagnostic and therapeutic process is regarded as clinically relevant because this is likely to translate in improved long-term stroke outcome at the population level. [12] The following secondary efficacy endpoints will be studied: 1. The prevalence of medical events diagnosed and corrected according to the current standing operating procedures for prehospital care at the UZB [20] during the in-ambulance teleconsultation, 2. The proportion of patients with ischemic stroke receiving recanalization therapy, 3. The assessment of the disability, the functional status, the quality of life and overall well-being using the modified Rankin Scale (mRS), [22] Barthel Index, [23] Euroquol (EQ-5D) [24] and WHO-Five Well-Being Index, [25] respectively, at 30, 90, 180 and 365 days after stroke.
Safety analysis
Mortality at 90 days after stroke will be the primary safety endpoint. Secondary safety analysis will involve the registration of any adverse event and will look particularly at known complications of delayed stroke care and thrombolytic therapy (in-hospital mortality, symptomatic intracranial hemorrhage, systemic bleeding after thrombolytic therapy requiring transfusion or inappropriate use of recanalization therapy, as defined by review of the patient files and video recordings by a panel of independent stroke experts).
Feasibility analysis
The endpoints for feasibility analysis include: 1. The proportion of successful in-ambulance telemedicine consultations, 2. The proportion of successful prehospital "Code Stroke" activations, 3. The prevalence of technical issues with regard to wireless connectivity, audio quality, video quality, webbased telemedicine platform, 4. Questionnaire-based acceptance of all stakeholders, 5. Prehospital time consumption (e.g., call-to-admission time, duration of the teleconsultation) and 6. Technical observations regarding the bandwidth of the mobile connection.
Reliability analysis
The concurrent validity of the prehospital telemedicine diagnosis and assessment of clinical scales (GCS and UTSS) will be evaluated by correlation with the final inhospital diagnosis and clinical scales. The reliability of the prehospital telemedicine diagnosis and assessment of clinical scales (GCS and UTSS) will be evaluated by the interrater variability, the intrarater variability and the rater agreement using the video recordings of the teleconsultations. The predictive validity of the UTSS obtained via in-ambulance telemedicine will be assessed by correlation with the mRS score and mortality at 90 days. The accuracy of the UTSS to differentiate between largevessel and small-vessel stroke will be assessed by correlation with the Oxfordshire Community Stroke Project (OCSP) classification and with the vessel status obtained in-hospital.
Health economic evaluation
A cost-utility analysis with societal perspective will be performed comparing the teleconsultation group with the standard care group. Resource utilization in both groups will be derived from claims' data during hospitalization and self-reporting for the period post discharge. Unit costs will be derived from national registries. Utilities will be measured by the EQ-5D surveys at 1 year post stroke. The health economic evaluation will be performed by decision -analytical modeling. A decision tree will be developed and populated with trial data wherever possible, which will model the short-term consequences (for the duration of hospital stay). Additionally, a Markov model will be used to model the outcomes over a long-term horizon. The latter will be based on national data [26] and findings from the CERISE study [27] [28] [29] and completed with information from the international peer-reviewed literature.
A probabilistic sensitivity analysis, in which the crucial variables will be varied, will be performed to account for the uncertainties. Incremental cost-effectiveness ratios will be calculated and evaluated on willingness-to-pay thresholds.
Data Safety Monitoring Board (DSMB)
An independent DSMB has reviewed and approved the trial protocol and will monitor the conduction of the trial. Interim analyses of adverse events will be performed after enrolment of 46 and 92 patients. The DSMB will continuously monitor the rate of serious adverse events and suspected unexpected adverse reactions. The DSMB may at any time recommend an amendment to the clinical trial protocol or termination of the trial in case of safety concerns.
Sample size
The sample size calculation is based on the primary efficacy endpoint (i.e., call-to-brain imaging time). Thanks to the facilitation of the stroke diagnosis process by in-ambulance telemedicine, we expect the call-to-brain imaging time on average to be 20 min less in the PreSSUB group compared with the control group. Accurate national information regarding call-to-brain imaging times for patients arriving at emergency departments by ambulances is not available. The best estimate for the average call-to-brain imaging time in UZB is 110 min (standard deviation, 40 min). In order to demonstrate the expected reduction in call-to-brain imaging time (i.e., to reject the null hypothesis of an identical call-to-brain imaging time in both groups) with a type-1 error α = 0.05 (two-tailed), a power of 80% (β = 20%) is achieved with a sample size of 128 patients (n = 64 per treatment group). Accounting for possible treatment failures, protocol violations and drop-outs, we plan to enroll 140 patients (n = 70 per treatment group).
Statistical plan
All analyses will be conducted according to the intentionto-treat principle and the per protocol principle. All efforts will be made to minimize the amount of missing data. Sensitivity analyses based on different hypotheses about the missingness pattern of the primary outcome will be performed to test for the robustness of the primary analysis.
Following a descriptive analysis, the distribution of outcomes between patient groups will be compared using the Mann-Whitney U test, the χ² test or the Fisher exact test. Multivariate regression analysis will be performed and shift analysis of the mRS score will be assessed by the van Elteren Cochran-Mantel-Hanszel test. Survival analysis using the Kaplan-Meier method and the Cox proportional hazards multivariate analysis will be performed. The interrater variability and the intrarater rater variability will be evaluated using the Spearman's ρ correlation, the χ² test or the Fisher exact test. The rater agreement will be tested using the intraclass correlation coefficient for single measures and weighted c statistics. The concurrent validity of the clinical scales will be assessed by the Spearman's ρ correlation. To assess the UTSS' predictive validity for outcome and its accuracy to differentiate between large-vessel and smallvessel stroke, we will assess the Spearman's ρ correlation with the mRS score and the correlation with the OCSP classification and with the vessel status obtained inhospital. Receiver operating curves, χ-statistics, optimal thresholds, likelihood ratios and accuracy measures will be calculated. Linear or generalized linear models will be used to analyze determinants for health care utilization and costs. A similar approach will be used to compare the level and evolution of quality of life and well-being between the intervention and the control group.
Study organization and funding
